MedPath

Homoeopathic treatment in adenomyosis

Phase 3
Conditions
Health Condition 1: N800- Endometriosis of uterus
Registration Number
CTRI/2024/05/067451
Lead Sponsor
Arup Kumar Mondal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Female patient with a positive diagnostic

finding for adenomyosis.

2. Women of age group 18-60 years.

3. Patients willing to give consent for

participating in the study.

4. Patients who can read Bengali and/or Hindi and/or English.

Exclusion Criteria

1. Pregnant women or lactating mothers.

2. Diagnosed cases of unstable psychiatric illness

or other systemic disease affecting

quality of life or some life-threatening illness.

3. Patients not willing to participate in the study.

4. Substance abuse and/or dependence.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umeric Rating Scale (NRS) Measurement for menstrual pain. The NRS is one of <br/ ><br>the most commonly used scales having a range from 0-10, where ‘0’ denotes no pain <br/ ><br>and ‘10’ denotes worst possible pain imaginable. <br/ ><br>• Pictorial blood loss assessment chart (PBAC) measurement for menstrual <br/ ><br>bleeding. The chart consists of a series of diagrams which depict staining, clots and <br/ ><br>flooding. The number of sanitary pad/tampons used each day during menstruation is <br/ ><br>recorded by placing a tally mark in the next box. For scoring row total is multiplied by multiplying factor for each row.Timepoint: At baseline and 6 month
Secondary Outcome Measures
NameTimeMethod
n attempt will be made to show changes in the pathology through lab investigations – USG (lower abdomen and pelvis)/ TVS/MRI (lower abdomen and pelvis)Timepoint: At baseline and 6 month
© Copyright 2025. All Rights Reserved by MedPath